[EN] N-(PYRIDIN-2-YL)-6,7,8,9-TETRAHYDRO-5H-5,8-EPIMINOCYCLOHEPTA[C]PYRIDINE-10-CARBOXAMIDE DERIVATIVES AND SIMILAR COMPOUNDS AS GPR65 MODULATORS FOR THE TREATMENT OF CANCER<br/>[FR] DÉRIVÉS DE N-(PYRIDIN-2-YL)-6,7,8,9-TÉTRAHYDRO-5H-5,8-EPIMINOCYCLOHEPTA[C]PYRIDINE-10-CARBOXAMIDE ET COMPOSÉS SIMILAIRES SERVANT DE MODULATEURS DE GPR65 POUR TRAITER LE CANCER
申请人:PATHIOS THERAPEUTICS LTD
公开号:WO2022136844A1
公开(公告)日:2022-06-30
The present invention relates to compounds of formula (I) as GPR65 modulators for the treatment of a proliferative disorder, such as e.g. cancer, an immune disorder, asthma, chronic obstructive pulmonary disease (CORD) or acute respiratory distress syndrome (ARDS). Preferred compounds are e.g. N-(Pyridin-2-yl)-6,7,8,9- tetrahydro-5H-5,8-epiminocyclohepta[c]pyridine-10-carboxamide derivatives and similar compounds, such as e.g. (5R,8S)-N- (4-chloro-5-(trifluoromethyl)pyridin-2-yl)-l-fluoro-6,7,8,9- tetrahydro-5H-5,8-epiminocyclohepta[c]pyridine-10-carboxamide (compound 1)
本发明涉及式(I)化合物作为GPR65调节剂,用于治疗增殖性疾病,例如癌症、免疫性疾病、哮喘、慢性阻塞性肺病(COPD)或急性呼吸窘迫综合征(ARDS)。优选的化合物例如是N-(吡啶-2-基)-6,7,8,9-四氢-5H-5,8-环丙氨基七环[c]吡啶-10-羧酰胺衍生物和类似化合物,例如(5R,8S)-N-(4-氯-5-(三氟甲基)吡啶-2-基)-1-氟-6,7,8,9-四氢-5H-5,8-环丙氨基七环[c]吡啶-10-羧酰胺(化合物1)。